Clinical trial
Controlled, Randomized, Prospective, Double-Blind, Multicenter, Phase I/II, Dose-Escalation Study of the Safety, PK, and Efficacy of YSPSL for Prevention of Delayed Graft Function in Patients Undergoing Cadaveric Kidney Transplantation
NCT00298181 is registered in ClinicalTrials.gov with Y's Therapeutics, Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Controlled, Randomized, Prospective, Double-Blind, Multicenter, Phase I/II, Dose-Escalation Study of the Safety, PK, and Efficacy of YSPSL for Prevention of Delayed Graft Function in Patients Undergoing Cadaveric Kidney Transplantation
- Lead sponsor
- Y's Therapeutics, Inc.
- Phase
- Observational
- Overall status
- Completed
- Start date
- October 31, 2005
- Completion date
- December 31, 2007
- Enrollment
- 15 (actual)
- Sites
- 10
Conditions
As the registry lists them; a condition with its own page is linked.